A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced Cancers
This study is currently recruiting participants.
Verified March 2013 by Merrimack Pharmaceuticals
Sponsor:
Merrimack Pharmaceuticals
Collaborator:
Sanofi
Information provided by (Responsible Party):
Merrimack Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT01451632
First received: October 7, 2011
Last updated: March 28, 2013
Last verified: March 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | October 2013 |
| Estimated Primary Completion Date: | June 2013 (Final data collection date for primary outcome measure) |